AIM Cancellation - Summit Therapeutics PLC (7948D)

TIDMSUMM

RNS Number : 7948D

AIM

24 February 2020

NOTICE

24/02/2020

NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM - XLON

At the request of the Company the following securities have been cancelled from trading on AIM with effect from the time and date of this notice.

 
SUMMIT THERAPEUTICS PLC 
213800NRW8AOMYMTBD89 
ORDINARY SHARES     (BN40HZ0)(GB00BN40HZ01)  SUMT THER/PAR VTG FDP 0.01 
 OF 1P EACH, FULLY 
 PAID 
                    -----------------------  --------------------------

If you have any queries or require further information, please contact the company's nominated adviser +44 (0)20 7213 0880.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

AMOUASVRRRUUUAR

(END) Dow Jones Newswires

February 24, 2020 02:00 ET (07:00 GMT)

Summit Therapeutics (LSE:SUMM)
Historical Stock Chart
From Oct 2024 to Nov 2024